Advertisement

Topics

Companies Related to "Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen" [Most Relevant Company Matches] RSS

15:52 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen" found in our extensive corporate database of over 50,000 company records.

Showing "Ranibizumab Treatment Choroidal Neovascularisation Secondary Pathological Myopia Individualized" Companies 1–25 of 3,400+

Relevant

Clearside Biomedical Inc.

Clearside Biomedical, based in Atlanta, is a clinical-stage ophthalmic pharmaceutical company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases. Clearside treats the pathological changes to the blood retinal barrier that lead to retinal blindness by delivering therapeutics through the suprachoroidal space ...


Bone Care International Incorporated

Bone Care is a leader in the discovery and development of improved vitamin D-hormone therapies for the treatment of secondary hyperparathyroidism and certain hyperproliferative diseases. D-hormones have a key role in the progression and management of secondary hyperparathyroidism in patient populations with kidney dysfunction, including kidney Dialysis, pre-dialysis, and certain osteoporosis pati...

Leading Edge Recovery Center

Leading Edge Recovery Center does a NJ-SAMS, ASI, ASAM PPC-2 assessment, and bio-psychosocial history and assessment to determine the level of care needed along with the treatment issues that need to be addressed, A Primary Counselor is assigned to each client at admission to direct client treatment through the assessment, treatment plan development, indiv...


InNexus Biotechnology, Inc.

approaches that add secondary properties to monoclonal antibodies (binding is a primary property) and applies to virtually every antibody product currently in development. Adding these secondary properties can increase the potency of antibodies or add new properties such as the ability to penetrate into living cells.As an example, InNexus utilized SAT with a humanized monoclonal antibody, licensed...

Nanobiotech

NanoBiotech is a life science company that discovers, develops, and manufactures novel nanobiotics designed to improve people's health through the treatment of diseases associated with pathological calcification, inflammation and nanobacterial infections. Our Founders’ pioneering research has established the role of Nanobacteria in pathological calcification: particularly in the development o...

La Ventana Treatment Programs

La Ventana Treatment Programs focus on understanding the complexity and progressive nature of eating disorders and substance abuse. Individuals seeking recovery may struggle with addictive behaviors and other underlying problems such as depression, anxiety, trauma, chronic pain and compulsive behaviors that may have blocked past attempts to free themselves...

Cancer Treatment Centers of America (CTCA)

Cancer Treatment Centers of America (CTCA) is a growing network of regional destination hospitals specializing in complex and advance-stage cancer care. CTCA provides a comprehensive, fully integrated and individualized cancer treatment experience at regional hospitals located in Chicago, Philadelphia, Phoenix and Tulsa. The Patient Empowered Care® mode...

Lorantis

Lorantis is discovering and developing breakthrough products for the selective treatment of immunological and inflammatory diseases based on immune regulation: the induction of antigen-specific tolerance. Current therapies for immunological and inflammatory diseases either relieve only the symptoms or induce non-specific suppression of the immune system. This can lead to severe infection and drug-...

KEW Group Inc.

KEW Group Inc. (KEW) is revolutionizing cancer care by empowering oncologists with access to genomic insights to design optimal, individualized treatment approaches for patients. KEW Group’s comprehensive set of products and solutions are designed to provide clarity above the complexity of genome-guided, personalized cancer therapy, arming oncologists...

Cancer Treatment Centers of America and Cigna

CTCA is a growing network of regional destination hospitals specializing in complex and advance-stage cancer care. CTCA provides a comprehensive, fully integrated and individualized cancer treatment experience at hospitals located in suburban Chicago, Philadelphia, suburban Phoenix and Tulsa, with a fifth hospital opening in Atlanta in the summer of 2012. ...

INTELECOM Intelligent Telecommunications

Since its founding more than 40 years ago, INTELECOM Intelligent Telecommunications® - a 501(c)3 non-profit corporation operated by a joint powers authority of 31 California community colleges - has been a leader in the design, production and distribution of distance learning courseware and instructional media for post-secondary, secondary, adult basic ...

Hanley Center

Headquartered in West Palm Beach, Fla., Hanley Center is a non-profit organization that offers a broad spectrum of programs that are based on the most advanced research in the disease of addiction. From detoxification and medical stabilization to individualized treatment and continuing-care planning, Hanley Center prides itself on offering the most innovative and effective treatment programs desig...

Castlewood Treatment Center

Castlewood Treatment Center helps people with eating disorders transform to healthier lives. Established in 2000 as the first residential treatment facility in Missouri, Castlewood’s licensed health care team is nationally recognized and has decades of combined experience in providing compassionate, professional and successful treatment for more than ...

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals understand how individualized genomic profiling of tumor tissue may help improve cancer management. The first diagnostic assay developed by Genomic Health — Oncotype DX™ — is a breast cancer test t...

AstraZeneca and Bristol-Myers Squibb

Dedicated to addressing the global burden of diabetes by advancing individualized patient care, AstraZeneca and Bristol-Myers Squibb are working in collaboration to research, develop and commercialize a versatile portfolio of innovative treatment options for diabetes and related metabolic disorders that aim to provide treatment effects beyond glucose contr...

AstraZeneca and Bristol-Myers Squibb Company

Dedicated to addressing the global burden of diabetes by advancing individualized patient care, AstraZeneca and Bristol-Myers Squibb are working in collaboration to develop and commercialize a versatile portfolio of innovative treatment options for diabetes and related metabolic disorders that aim to provide treatment effects beyond glucose control. Find o...

Professionals Treatment Program

The Professionals Treatment Program will continue to offer individualized 72 hour multidisciplinary evaluations through its Comprehensive Diagnostic Evaluation (CDE) program, now directed by John Pustaver, M.Div., MA., the former long-term director of the evaluation program at the Betty Ford Center. CDE’s are conducted for licensed professionals, such...

Notal Vision, Inc.

Notal Vision was founded by two ophthalmologists, and is committed to providing retina specialists with innovative, home-based, technology solutions that support visual health in patients with AMD. The company's ForeseeHome® device is the first FDA-cleared home telemonitoring device that detects and characterizes visual distortion in AMD patients as an ...

The Montreal Fertility center

Welcome to The Montreal Fertility CenterThe Montreal Fertility Centre has been created in order to offer the highest level of individualized treatment to uor patients.Here,you will always see the familiar face of your own health professional who knows your medical history in detail,and is therefore in a position to offer the most appropriate care.We believe that seeing the same medical professiona...

BioNTech AG

BioNTech is Europe’s largest privately-held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks for individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from indi...

Avedro, Inc.

Avedro, a privately held medical device company based in Waltham, MA, is developing the science of Thermo-biomechanics for therapeutic medical applications. Keraflex® KXL is the first technology Avedro has developed from its Thermo-biomechanics platform. Avedro recently announced it has signed a definitive agreement with Peschke Meditrade GmbH to acquir...

WestBridge

With locations in Florida, New Hampshire and Massachusetts, WestBridge, Inc. has been supporting the recovery of individuals and families that experience co-occurring mental illness and substance use disorders since 2001. As a private 501(c)(3) nonprofit treatment program, WestBridge provides a unique clinical setting in which evidence-based treatment for ...

BioNTech and Genevant Sciences

BioNTech is Europe’s largest privately-held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks for individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from indi...

Singapore National Eye Centre

Singapore National Eye Centre (SNEC) was incorporated in 1989 and commenced operations in 1990. It is the designated centre within the public sector healthcare network to spearhead and co-ordinate the rovision of specialised ophthalmological services with emphasis on quality education and research. Since its opening in 1990, SNEC has achieved rapid growth and currently manages an annual workload o...

MiniVax, Inc.

MiniVax is a New Orleans, LA based company that specializes in the research and development of novel vaccines and therapeutics for the treatment and prevention of opportunistic fungal and bacterial infections. MiniVax’s lead product is a vaccine against the opportunistic fungal infection Pneumocystis pneumonia (PCP), which predominately affects immuno...


More From BioPortfolio on "Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks